Lantus Solostar Sanofi

£241.00

Lantus Solostar Sanofi is a long-acting insulin glargine formulation developed for extended glucose regulation research. Each pre-filled pen delivers 300 units of insulin for precise laboratory studies examining metabolic pathways and diabetes-related molecular mechanisms.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Lantus Solostar Sanofi
Lantus Solostar Sanofi
£241.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Insulin Research Overview

Lantus Solostar Sanofi is a long-acting insulin glargine formulation specifically engineered for in-vitro metabolic research applications. This recombinant human insulin analogue represents a cornerstone tool for investigating glucose homeostasis, cellular metabolism, and insulin receptor signalling pathways in laboratory settings. Researchers at Stroid UK Shop can access this pharmaceutical-grade compound for comprehensive studies examining insulin-dependent molecular mechanisms and diabetes-related metabolic dysfunction models.

Laboratory Research Applications

Research scientists utilise Lantus Solostar for investigating prolonged insulin activity profiles, examining how modified insulin structures affect receptor binding kinetics, and studying cellular glucose uptake mechanisms. The compound proves invaluable for diabetes research protocols, metabolic syndrome investigations, and pancreatic beta-cell function studies. Laboratory applications extend to examining insulin resistance development, evaluating glucose transport proteins, and investigating the molecular basis of glycemic control. Researchers exploring broader metabolic pathways often combine insulin studies with investigations into SARMs for comprehensive metabolic research protocols. Advanced studies may incorporate peptides alongside insulin research to examine complex hormonal interactions and metabolic signalling cascades.

Technical Specifications

Lantus Solostar Sanofi Research Specifications
Parameter Specification
Active Ingredient Insulin Glargine
Concentration 300 units/3mL
Delivery System Pre-filled disposable pen
Storage Temperature 2-8°C refrigerated
Manufacturer Sanofi
Research Grade Pharmaceutical standard

Research Compliance Statement

This insulin preparation is intended exclusively for in-vitro laboratory research examining metabolic pathways, cellular glucose regulation, and diabetes-related molecular mechanisms. Researchers investigating metabolic modulators within our general health insulin category must ensure appropriate laboratory protocols and safety measures. This product is not intended for human consumption, therapeutic use, or any application outside controlled laboratory environments. All research must comply with institutional guidelines and regulatory requirements for biochemical research involving insulin compounds.

Related